Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cuthbertson

Showing results (11-20 of 241) with videos related to

Pageof 25
Sort By:
The Journal of Physiology|July 22, 2017
Higher levels of cardiorespiratory fitness keep liver mitochondria happy!Daniel J Cuthbertson, Kelly Bowden Davies
Nature Reviews. Endocrinology|July 17, 2021
Metabolically healthy obesity: time for a change of heart?Daniel J Cuthbertson, John P H Wilding
Frontiers in Nutrition|March 5, 2021
The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories?Theresa Hydes, Uazman Alam, Daniel J Cuthbertson
Therapeutic Advances in Endocrinology and Metabolism|September 11, 2020
COVID-19 and obesity: an opportunity for changeDan J Cuthbertson, Uazman Alam, Abd Tahrani
Clinical Medicine (London, England)|March 23, 2023
Diagnosis and management of neuroendocrine tumoursDaniel J Cuthbertson, Rebecca Shankland, Raj Srirajaskanthan
Lancet (London, England)|March 29, 2001
Clinical picture: occult ectopic ACTH syndromeD J Cuthbertson, S Vinjamuri, D Bowen-Jones
Obesity (Silver Spring, Md.)|December 12, 2022
Reduced muscle strength (dynapenia) in women with obesity confers a greater risk of falls and fractures in the UK BiobankLisa Dowling, Daniel J Cuthbertson, Jennifer S Walsh
Rheumatology (Oxford, England)|March 29, 2024
Human genetic evidence supports fibroblast growth factor 21 as a novel therapeutic target for goutSizheng Steven Zhao, Daniel J Cuthbertson, Uazman Alam
Chemical Communications (Cambridge, England)|January 21, 2014
Observations on transition metal free biaryl coupling: potassium tert-butoxide alone promotes the reaction without diamine or phenanthroline catalystsJ Cuthbertson, V J Gray, Jonathan D Wilden
Peptides|February 8, 2018
Newer GLP-1 receptor agonists and obesity-diabetesEmily Brown, Daniel J Cuthbertson, John P Wilding
Pageof 25

Showing results (11-20 of 241) with videos related to

Sort By:
Pageof 25
The Journal of Physiology|July 22, 2017
Higher levels of cardiorespiratory fitness keep liver mitochondria happy!Daniel J Cuthbertson, Kelly Bowden Davies
Nature Reviews. Endocrinology|July 17, 2021
Metabolically healthy obesity: time for a change of heart?Daniel J Cuthbertson, John P H Wilding
Frontiers in Nutrition|March 5, 2021
The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories?Theresa Hydes, Uazman Alam, Daniel J Cuthbertson
Therapeutic Advances in Endocrinology and Metabolism|September 11, 2020
COVID-19 and obesity: an opportunity for changeDan J Cuthbertson, Uazman Alam, Abd Tahrani
Clinical Medicine (London, England)|March 23, 2023
Diagnosis and management of neuroendocrine tumoursDaniel J Cuthbertson, Rebecca Shankland, Raj Srirajaskanthan
Lancet (London, England)|March 29, 2001
Clinical picture: occult ectopic ACTH syndromeD J Cuthbertson, S Vinjamuri, D Bowen-Jones
Obesity (Silver Spring, Md.)|December 12, 2022
Reduced muscle strength (dynapenia) in women with obesity confers a greater risk of falls and fractures in the UK BiobankLisa Dowling, Daniel J Cuthbertson, Jennifer S Walsh
Rheumatology (Oxford, England)|March 29, 2024
Human genetic evidence supports fibroblast growth factor 21 as a novel therapeutic target for goutSizheng Steven Zhao, Daniel J Cuthbertson, Uazman Alam
Chemical Communications (Cambridge, England)|January 21, 2014
Observations on transition metal free biaryl coupling: potassium tert-butoxide alone promotes the reaction without diamine or phenanthroline catalystsJ Cuthbertson, V J Gray, Jonathan D Wilden
Peptides|February 8, 2018
Newer GLP-1 receptor agonists and obesity-diabetesEmily Brown, Daniel J Cuthbertson, John P Wilding
Pageof 25